NCT00226382View on ClinicalTrials.gov

Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Chronic Hepatitis B
Interventions
DRUG

Pegylated Interferon-alfa-2a

Pegasys once weekly

Trial Locations (1)

Unknown

Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Chinese University of Hong Kong

OTHER

NCT00226382 - Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment | Biotech Hunter | Biotech Hunter